Intercell chronicles

Intercell chroniclesShares of Intercell (VSE:ICLL) have risen steadily since the company went public on the Vienna Stock Exchange in February 2005. Last week's deal with Novartis Vaccines & Diagnostics makes Novartis (NVS; SWX:NOVN) the company's largest shareholder with a 16.2% stake. Other major shareholders are Temasek Holdings (7.2%) and ATI Vermögenstreuhand (Kapital & Wert Group) (4.9%). The current free float is 68.9%. Selected ICLL events below are tracked against the weekly stock price. A. 2/28/05 - Raises E46.8M ($61.9M) in an IPO on the Vienna Stock Exchange

B. 4/6/06 - Grants Kirin (Tokyo:2503; KNBWY) global rights to develop and commercialize human MAbs against antigens detected by ICLL's Antigen Identification Program (AIP) to treat Streptococcus pneumoniae ...